drug
natalizumab biosimilar
Marketedupdated 6mo agoby Sandoz Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(3)
Trials studying natalizumab biosimilar
News(1)
- STAT+: Dutch antitrust regulators probe Biogen over test for its MS drugDutch antitrust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.stat · 9d ago
Data sources
last refreshed 7h ago
Found something off?
comments(0)
5-min edit window · permanent after that